Davide Leone & Partners Investment Company’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-105,101	Closed	-$1.84M	–	109
2020 Q4	$1.84M	Buy	+105,101	New	+$1.47M	0.19%	32

Davide Leone & Partners Investment Company's OXFD Position: Q1 2021 in Review

Davide Leone & Partners Investment Company sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 105,101 shares — an estimated $1.84M sold.

Davide Leone & Partners Investment Company first reported a position in OXFD in Q4 2020 and held it in 1 quarter. The position peaked at $1.84M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Davide Leone & Partners Investment Company reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 105,101 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.84M.
Davide Leone & Partners Investment Company first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2020 and held it in 1 quarter.
Davide Leone & Partners Investment Company's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.84M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q1 2021, filed 17 May 2021.